Impax Laboratories, LLC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$54.9M

763 transactions

Summary

Impax Laboratories, LLC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $2.4MSales: $22.2M23 insiders

Date	Insider	Type	Value
2018-05-04	BISARO PAUL(President and CEO)	D	—
2018-05-04	Reasons Bryan M.(Chief Financial Officer)	D	—
2018-05-04	Reasons Bryan M.(Chief Financial Officer)	D	—
2018-05-04	Reasons Bryan M.(Chief Financial Officer)	D	—
2018-05-04	Reasons Bryan M.(Chief Financial Officer)	D	—
2018-05-04	Reasons Bryan M.(Chief Financial Officer)	D	—
2018-05-04	Reasons Bryan M.(Chief Financial Officer)	D	—
2018-05-04	Reasons Bryan M.(Chief Financial Officer)	D	—
2018-05-04	Boothe Douglas(President, Generics Division)	D	—
2018-05-04	Boothe Douglas(President, Generics Division)	D	—
2018-05-04	Boothe Douglas(President, Generics Division)	D	—
2018-05-04	Boothe Douglas(President, Generics Division)	D	—
2018-05-04	NESTOR MICHAEL(President, Impax Specialty)	D	—
2018-05-04	NESTOR MICHAEL(President, Impax Specialty)	D	—
2018-05-04	NESTOR MICHAEL(President, Impax Specialty)	D	—
2018-05-04	NESTOR MICHAEL(President, Impax Specialty)	D	—
2018-05-04	NESTOR MICHAEL(President, Impax Specialty)	D	—
2018-05-04	NESTOR MICHAEL(President, Impax Specialty)	D	—
2018-05-04	NESTOR MICHAEL(President, Impax Specialty)	D	—
2018-05-04	NESTOR MICHAEL(President, Impax Specialty)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Impax Laboratories, LLC — Contributions, Lobbying & Contracts | Poliscope